Group 1 - The core viewpoint of the news is that Maide Medical's stock has experienced a decline of 5.07%, with a current price of 19.47 CNY per share and a total market capitalization of 3.236 billion CNY [1] - Maide Medical, established on March 10, 2003, and listed on December 3, 2019, specializes in the research, production, sales, and service of medical consumables and intelligent equipment [1] - The main revenue composition of Maide Medical includes: 42.18% from safety infusion line machines, 37.90% from blood purification line machines, 14.04% from safety infusion single machines, and 5.87% from other categories [1] Group 2 - Among the top ten circulating shareholders of Maide Medical, a fund under Rongtong Fund holds a position, having reduced its holdings by 156 shares in the first quarter, now owning 2.5998 million shares, which is 1.56% of the circulating shares [2] - The Rongtong Health Industry Flexible Allocation Mixed A/B fund (000727) has a current scale of 2.074 billion CNY and has achieved a return of 23.63% this year, ranking 3072 out of 8194 in its category [2] - The fund has a one-year return of 47%, ranking 2642 out of 7963, and a cumulative return since inception of 198.7% [2]
迈得医疗股价跌5.07%,融通基金旗下1只基金位居十大流通股东,持有259.98万股浮亏损失270.38万元